메뉴 건너뛰기




Volumn 106, Issue 2, 2011, Pages 177-181

The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors

Author keywords

D30N; Drug resistance; Hypersusceptibility; N88D; Phenotyping; Protease inhibitors

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79955413988     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000200010     Document Type: Article
Times cited : (7)

References (22)
  • 1
    • 0037118912 scopus 로고    scopus 로고
    • M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine
    • CNA3002 International Study Team
    • Ait-Khaled M, Stone C, Amphlett G, Clotet B, Staszewski S, Katlama C, Tisdale M, CNA3002 International Study Team 2002. M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine. AIDS 16: 1686-1689.
    • (2002) AIDS , vol.16 , pp. 1686-1689
    • Ait-Khaled, M.1    Stone, C.2    Amphlett, G.3    Clotet, B.4    Staszewski, S.5    Katlama, C.6    Tisdale, M.7
  • 2
    • 63149156274 scopus 로고    scopus 로고
    • Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors
    • Aoki M, Venzon DJ, Koh Y, Aoki-Ogata H, Miyakawa T, Yoshimura K, Maeda K, Mitsuya H 2009. Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors. J Virol 83: 3059-3068.
    • (2009) J Virol , vol.83 , pp. 3059-3068
    • Aoki, M.1    Venzon, D.J.2    Koh, Y.3    Aoki-Ogata, H.4    Miyakawa, T.5    Yoshimura, K.6    Maeda, K.7    Mitsuya, H.8
  • 3
    • 1442355578 scopus 로고    scopus 로고
    • HIV drug resistance
    • Clavel F, Hance AJ 2004. HIV drug resistance. N Engl J Med 350: 1023-1035.
    • (2004) N Engl J Med , vol.350 , pp. 1023-1035
    • Clavel, F.1    Hance, A.J.2
  • 5
    • 34748818983 scopus 로고    scopus 로고
    • Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments
    • Spanish Group for the Study of Antiretroviral Drug Resistance
    • Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Nájera R, Pumarola T, Alonso-Socas M, del M, García-Bujalance S, Menéndez-Arias L, Spanish Group for the Study of Antiretroviral Drug Resistance 2007. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments. J Med Virol 79: 1617-1628.
    • (2007) J Med Virol , vol.79 , pp. 1617-1628
    • Garriga, C.1    Pérez-Elías, M.J.2    Delgado, R.3    Ruiz, L.4    Nájera, R.5    Pumarola, T.6    Alonso-Socas, M.7    Del, M.8    García-Bujalance, S.9    Menéndez-Arias, L.10
  • 6
    • 33750253231 scopus 로고    scopus 로고
    • Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
    • Hemelaar J, Gouws E, Ghys PD, Osmanov S 2006. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20: W13-W23.
    • (2006) AIDS , vol.20
    • Hemelaar, J.1    Gouws, E.2    Ghys, P.D.3    Osmanov, S.4
  • 10
    • 0028085161 scopus 로고
    • Recombinant virus assay: A rapid, phe-notypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates
    • Kellam P, Larder BA 1994. Recombinant virus assay: a rapid, phe-notypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother 38: 23-30.
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 23-30
    • Kellam, P.1    Larder, B.A.2
  • 11
    • 0242659106 scopus 로고    scopus 로고
    • Amprenavir resistance imparted by the I50V mutation in HIV-1 protease can be suppressed by the N88S mutation
    • Lam E, Parkin NT 2003. Amprenavir resistance imparted by the I50V mutation in HIV-1 protease can be suppressed by the N88S mutation. Clin Infect Dis 37: 1273-1274.
    • (2003) Clin Infect Dis , vol.37 , pp. 1273-1274
    • Lam, E.1    Parkin, N.T.2
  • 12
    • 0029028067 scopus 로고
    • Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
    • Larder BA, Kemp SD, Harrigan PR 1995. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269: 696-699.
    • (1995) Science , vol.269 , pp. 696-699
    • Larder, B.A.1    Kemp, S.D.2    Harrigan, P.R.3
  • 13
  • 16
    • 3342913702 scopus 로고    scopus 로고
    • Distribution of human immunodeficiency virus type 1 protease and reverse tran-scriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing
    • Rhee SY, Liu T, Ravela J, Gonzales MJ, Shafer RW 2004. Distribution of human immunodeficiency virus type 1 protease and reverse tran-scriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing. Antimicrob Agents Chemother 48: 3122-3126.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 3122-3126
    • Rhee, S.Y.1    Liu, T.2    Ravela, J.3    Gonzales, M.J.4    Shafer, R.W.5
  • 18
    • 0141631851 scopus 로고    scopus 로고
    • Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART
    • Røge BT, Katzenstein TL, Nielsen HL, Gerstoft J 2003. Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART. HIV Med 4: 38-47.
    • (2003) HIV Med , vol.4 , pp. 38-47
    • Røge, B.T.1    Katzenstein, T.L.2    Nielsen, H.L.3    Gerstoft, J.4
  • 19
    • 0033965761 scopus 로고    scopus 로고
    • Human immunodeficiency virus reverse transcriptase and protease sequence database
    • Shafer RW, Jung DR, Betts BJ, Xi Y, Gonzales MJ 2000. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 28: 346-348.
    • (2000) Nucleic Acids Res , vol.28 , pp. 346-348
    • Shafer, R.W.1    Jung, D.R.2    Betts, B.J.3    Xi, Y.4    Gonzales, M.J.5
  • 22
    • 0034002883 scopus 로고    scopus 로고
    • A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir
    • Ziermann R, Limoli K, Das K, Arnold E, Petropoulos CJ, Parkin NT 2000. A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir. J Virol 74: 4414-4419.
    • (2000) J Virol , vol.74 , pp. 4414-4419
    • Ziermann, R.1    Limoli, K.2    Das, K.3    Arnold, E.4    Petropoulos, C.J.5    Parkin, N.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.